16 October 2025Publication
Actualités clés en IP - Octobre 2025
Un aperçu de l’actualité marquante du dernier trimestre en matière de Propriété Intellectuelle.
Our highly collaborative team works together across business areas and jurisdictions to deliver a full-service patent offering. Whether it’s complex litigation, drafting and prosecuting patent applications or advising on licensing, collaboration and commercial transactions, you’re in good hands.
We’re known for our expertise in the life sciences and technology sectors, covering technical fields such as pharmaceuticals, biotechnology, medical devices, telecommunications, electronics, chemicals and engineering. Most of our lawyers have technical backgrounds, including advanced degrees and scientific research experience.
But we don’t just follow the law, we shape it. Our lawyers have been at the forefront of legal developments for over 50 years and lead the way on key issues affecting the industry. We’ve been instrumental in drafting the UPC’s Rules and Procedure and are ahead of the market when it comes to advising on European litigation strategy.
Our areas of focus include:
- Conducting and co-ordinating national and multi-jurisdictional patent litigation
- Urgent applications, including preliminary injunctions
- Drafting and prosecuting patent applications
- Oppositions and validity challenges before the EPO and national patent offices
- Portfolio management
- Opinions on patent validity and infringement and freedom to operate
- Customs detention strategies
- Patent protection and litigation strategy and budgeting
Our experience
Biosimilars
Lead advisors as our client launches its portfolio of biosimilar products in Europe - competing with some of the world’s biggest selling pharmaceuticals. We have served as the hub for all their European IP needs in respect of their successful launch of a pipeline of biosimilar drugs. We have also provided litigation support and advise (internationally) on patent and regulatory issues.
Boston Scientific
Our team has represented Boston Scientific in several high value multi-jurisdictional patent disputes over more than 20 years. Most recently, Boston successfully enforced its patents against the global leader, Edwards Lifesciences, concerning transcatheter aortic replacement (TAVR) technology. Following a series of trials and appeals and post-judgment applications, the parties entered into a cross-licence with Edwards making a net balancing payment to Boston Scientific of $180m.
Global Pharmaceuticals
Our long-standing clients have instructed us to devise and implement patent litigation strategies as part of plans to launch blockbuster biologic products into competitive innovator and biosimilar markets. In Europe and across the globe. We advised on multiple national patent actions and devised and coordinated cross-border strategies with the US and Europe. Our network, technical expertise and experience in multiple patent court systems allowed us to navigate complex issues and achieve positive litigation outcomes. This included revoking patents in key jurisdictions, defending injunctions, obtaining innovative declaratory remedies for cross-border impact and applying litigation pressures to help drive commercial settlement.
Key contacts
If you have any questions, contact a member of the Patents team for assistance:
Related insights
22 August 2025 Publication
Plausibility in the UK – no change post G2/21
The UK Court of Appeal reaffirms the ab initio plausibility test in Generics v AstraZeneca, emphasising robust patent disclosure to avoid speculative claims.
16 July 2025 Publication
Agribusiness in the spotlight
Agribusiness in the spotlight. Plant breeders’ rights (PBRs) and innovation in the agricultural sector are not often litigated in the courts.
_11zon_11zon.jpg?width=380&width=380&format=webply&auto=webp "Article")
27 March 2025 Publication
Key decisions at the EPO and UPC
We cover some recent key decisions in European patent disputes, this time looking at developments in the EPO and the Unified Patent Court (UPC).
27 March 2025 Publication
European patent disputes from the EPO and UPC
We cover some recent key decisions in European patent disputes, from institutions like the EPO, UPC and other European courts.